This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Spalart V, et al. Dramatic response to first line single agent pembrolizumab in anaplastic thyroid carcinoma. Case Reports in Endocrinology 2019: 26 Nov 2019. Available from: URL: http://doi.org/10.1155/2019/9095753